ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
AnaptysBio Inc

AnaptysBio Inc (ANAB)

25.06
0.26
(1.05%)
Closed June 29 3:00PM
25.06
0.00
(0.00%)
After Hours: 3:03PM

Calls

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
12.5010.1015.000.0012.550.000.00 %00-
15.008.1012.500.0010.300.000.00 %00-
17.505.5010.000.007.750.000.00 %00-
20.003.207.500.005.350.000.00 %00-
22.502.405.300.003.850.000.00 %00-
25.000.602.001.051.30-0.30-22.22 %136/28/2024
30.000.004.900.000.000.000.00 %00-

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Puts

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
12.500.005.000.000.000.000.00 %00-
15.000.005.000.000.000.000.00 %00-
17.500.005.000.000.000.000.00 %00-
20.000.004.900.000.000.000.00 %00-
22.500.152.750.601.450.000.00 %01-
25.000.602.500.001.550.000.00 %00-
30.003.407.500.005.450.000.00 %00-

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ASNSActelis Networks Inc
US$ 2.4638
(66.47%)
68.83M
COSMCosmos Health Inc
US$ 1.06
(56.11%)
79.47M
LUCYInnovative Eyewear Inc
US$ 0.507001
(53.64%)
356.92M
NNENano Nuclear Energy Inc
US$ 22.7052
(39.98%)
8.73M
NBSTWNewbury Street Acquisition Corporation
US$ 0.0613
(39.32%)
19.62k
CINGCingulate Inc
US$ 0.315
(-46.06%)
2.36M
ACCDAccolade Inc
US$ 3.53
(-44.76%)
14.63M
BTOGBit Origin Ltd
US$ 2.95
(-44.55%)
3.3M
NXLNexalin Technologies Inc
US$ 1.695
(-42.74%)
4.31M
APVOAptevo Therapeutics Inc
US$ 0.309899
(-39.81%)
2.37M
LUCYInnovative Eyewear Inc
US$ 0.5036
(52.61%)
364.85M
NVDANVIDIA Corporation
US$ 123.54
(-0.36%)
315.71M
FFIEFaraday Future Intelligent Electric Inc
US$ 0.5052
(-15.80%)
197.64M
SQQQProShares UltraPro Short QQQ
US$ 8.28
(1.85%)
155.74M
PLUGPlug Power Inc
US$ 2.32
(-5.69%)
121.64M

ANAB Discussion

View Posts
gfp927z gfp927z 2 years ago
HighPeaks, The NY Times article was high profile, but the connection to ANAB isn't readily apparent.

Even with the partial sale/monetization of the revenue stream from dostarlimab in December, the drug is also being studied by Glaxo for other cancer types (endometrial, non-small cell lung, ovarian, and mismatch repair deficient solid tumors). One question to answer is whether the monetization deal with Sagard was only for colorectal, or for all the indications? Probably for all, but I'll have to do more research.

ANAB has numerous other programs and a large pile of cash, so looks interesting. But investing in biotech requires a ton of research, but even then you still don't know what you have, and landmines are everywhere. Better to invest in 'what you know', as Buffett recommends :o)




---
πŸ‘οΈ0
HighPeaks HighPeaks 2 years ago
Thanks TP. Yeah this has the potential to really be a big mover. So surprised no one has made the connection between this potential miracle drug and $ANAB receiving royalties on it(as it’s originator). GSK is the collaborator who has just commercialized it but it’s ANAB invention.
πŸ‘οΈ0
tedpeele tedpeele 2 years ago
Tremendous find HighPeaks. .You have been early on quite a few big movers. I'm thinking this is yet another one.

Will be watching this closely...thanks.
πŸ‘οΈ0
HighPeaks HighPeaks 2 years ago
According to this link ANAB gets 8-25% royalties from Dostarlimab. This drug has recently shown phenomenal results in a trial at Memorial Sloan Kettering Hospital. All patients fully recovered from rectal cancer.
https://www.globenewswire.com/fr/news-release/2020/10/26/2114250/0/en/AnaptysBio-and-GlaxoSmithKline-Amend-Strategic-Immuno-Oncology-Collaboration.html
πŸ‘οΈ0
TFMG TFMG 4 years ago

$ANAB | #Anaptysbio Spikes After Drug Designation


Nice spike in the afterhours session, lets hope we
can get some continuation tomorrow.
Target $29.00 to Fib Golden Pocket
Also a very large gap to fill at $35.00
AnaptysBio gets orphan drug designation of imsidolimab for pustular psoriasis
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.


πŸ‘οΈ0
LoveItInBishop LoveItInBishop 5 years ago
RSI @ 16. laughable. Zacks has positive take. https://finance.yahoo.com/news/anaptysbio-enters-oversold-territory-135501475.html
πŸ‘οΈ0
ClayTrader ClayTrader 5 years ago
* * $ANAB Video Chart 11-13-19 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
ClayTrader ClayTrader 5 years ago
* * $ANAB Video Chart 11-08-19 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
waterchaser waterchaser 5 years ago
LOL! Twitter PnD. Buyer beware.
πŸ‘οΈ0
420man 420man 5 years ago
Once the real bounce starts it will be fast....
πŸ‘οΈ0
Crazy Money Crazy Money 5 years ago
$10 to da moon
πŸ‘οΈ0
420man 420man 5 years ago
This will bounce..... 15 AH
πŸ‘οΈ0
RJ Trotts RJ Trotts 5 years ago
trying to bounce back over $11, hoping for more
πŸ‘οΈ0
TaxiCaT TaxiCaT 5 years ago
Ouch -
πŸ‘οΈ0
celle celle 5 years ago
Nothing happen here?
πŸ‘οΈ0
manny371 manny371 6 years ago
This stock is making noise! Bought in Sept $ANAB
πŸ‘οΈ0